5613 related articles for article (PubMed ID: 3744640)
1. Effect of tumor inhibitory and stimulatory doses of levan, alone and in combination with cyclophosphamide, on spleen and lymph nodes.
Leibovici J; Kopel S; Siegal A; Gal-Mor O
Int J Immunopharmacol; 1986; 8(4):391-403. PubMed ID: 3744640
[TBL] [Abstract][Full Text] [Related]
2. Effect of cyclophosphamide and levan treatment on bone marrow and peripheral blood cells in B16-F10 melanoma-bearing mice.
Leibovici J; Siegal A; Kopel S; Davidai G; Yavetz H
Int J Immunopharmacol; 1989; 11(2):133-47. PubMed ID: 2703278
[TBL] [Abstract][Full Text] [Related]
3. Histological changes in spleen and lymph nodes of mice administered cyclophosphamide and levan.
Siegal A; Kopel S; Leibovici J
Cell Tissue Res; 1986; 245(1):183-8. PubMed ID: 3488127
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects on tumor growth depending on dose of an immunomodulatory polysaccharide with or without cyclophosphamide.
Leibovici J; Kopel S; Wolman M
Anticancer Res; 1985; 5(5):553-8. PubMed ID: 4062258
[TBL] [Abstract][Full Text] [Related]
5. Modification of the tuberculin reaction by levan.
Shezen E; Leibovici J; Wolman M
Br J Exp Pathol; 1978 Oct; 59(5):454-8. PubMed ID: 718799
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow and peripheral blood modifications in C57BL mice administered with cyclophosphamide and levan.
Siegal A; Kopel S; Bar-Sela S; Davidai G; Yavetz H; Leibovici J
In Vivo; 1988; 2(5):349-59. PubMed ID: 2979857
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory and stimulatory effects of levan on growth of B16 melanoma--possible mechanisms.
Yavetz H; Davidai G; Leibovici J; Wolman M
Cell Mol Biol; 1985; 31(5):343-7. PubMed ID: 4084939
[No Abstract] [Full Text] [Related]
8. Effect of administration schedule on the levan-cyclophosphamide combined treatment of Lewis lung carcinoma.
Stark Y; Leibovici J; Wolman M
Int J Immunopharmacol; 1983; 5(4):289-97. PubMed ID: 6629589
[TBL] [Abstract][Full Text] [Related]
9. Combined effect of levan and cytotoxic agents on the growth of experimental tumours in mice.
Leibovici J; Stark Y; Wolman M
Br J Exp Pathol; 1983 Jun; 64(3):239-44. PubMed ID: 6882675
[TBL] [Abstract][Full Text] [Related]
10. Effect of splenectomy on treatment of Lewis lung carcinoma by an immunomodulatory polysaccharide and a cytotoxic agent.
Michowitz M; Kopel S; Hoenig S; Leibovici J
J Surg Oncol; 1987 Apr; 34(4):268-71. PubMed ID: 3560964
[TBL] [Abstract][Full Text] [Related]
11. Effect of splenectomy on the efficiency of chemo-immunotherapy of melanoma-bearing mice.
Kopel S; Michowitz M; Leibovici J
Int J Immunopharmacol; 1985; 7(6):801-10. PubMed ID: 4077343
[TBL] [Abstract][Full Text] [Related]
12. Suppression of humoral immune response in mice by administration of high molecular levan.
Hoenig S; Katzap I; Leibovici J
Experientia; 1978 Oct; 34(10):1362-3. PubMed ID: 738425
[TBL] [Abstract][Full Text] [Related]
13. Change from inhibition to stimulation by levan of AKR lymphoma following serial transfers.
Leibovici J; Hoenig S; Stark Y; Kopel S; Wolman M
Exp Cell Biol; 1984; 52(4):219-24. PubMed ID: 6734889
[TBL] [Abstract][Full Text] [Related]
14. Direct antitumor effect of the polysaccharide levan in mice: effects of drug concentration and time and temperature of incubation.
Leibovici J; Stark Y
J Natl Cancer Inst; 1984 Jun; 72(6):1417-20. PubMed ID: 6587158
[TBL] [Abstract][Full Text] [Related]
15. The inhibitory effects of high molecular levan on transport across the vascular wall stimulated by histamine.
Walters MN; Wolman M; Robertson TA; Papadimitriou JM
J Pathol; 1978 Apr; 124(4):195-203. PubMed ID: 722383
[TBL] [Abstract][Full Text] [Related]
16. Anamnestic responses induced by antigen persisting on follicular dendritic cells from cyclophosphamide-treated mice.
Phipps RP; Mandel TE; Schnizlein CT; Tew JG
Immunology; 1984 Feb; 51(2):387-97. PubMed ID: 6607214
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 increases intracellular glutathione levels and reverses the growth inhibiting effects of cyclophosphamide on B16 melanoma cells.
Palomares T; Alonso-Varona A; Alvarez A; Castro B; Calle Y; Bilbao P
Clin Exp Metastasis; 1997 May; 15(3):329-37. PubMed ID: 9174132
[TBL] [Abstract][Full Text] [Related]
18. Opposite effects on tumor growth depending on dose of Achyranthes bidentata polysaccharides in C57BL/6 mice.
Jin LQ; Zheng ZJ; Peng Y; Li WX; Chen XM; Lu JX
Int Immunopharmacol; 2007 May; 7(5):568-77. PubMed ID: 17386404
[TBL] [Abstract][Full Text] [Related]
19. Combination of HDAC inhibitor MS-275 and IL-2 increased anti-tumor effect in a melanoma model via activated cytotoxic T cells.
Kato Y; Yoshino I; Egusa C; Maeda T; Pili R; Tsuboi R
J Dermatol Sci; 2014 Aug; 75(2):140-7. PubMed ID: 24866536
[TBL] [Abstract][Full Text] [Related]
20. Different effects of the polysaccharide levan on the oncogenicity of cells of two variants of Lewis lung carcinoma.
Stark Y; Leibovici J
Br J Exp Pathol; 1986 Feb; 67(1):141-7. PubMed ID: 3947532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
